Stability studies on piroxicam encapsulated niosomes

Current Drug Delivery

Volumn 12, Issue 2, 2015, Pages 192-199

  Ertekin, Zehra Ceren ^a   Bayindir, Zerrin Sezgin ^a   Yuksel, Nilufer ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Drug release; Lyophilization; Niosomes; Piroxicam; Span 40; Stability

Indexed keywords

CRYOPROTECTIVE AGENT; NIOSOME; PIROXICAM; LIPOSOME;

AQUEOUS SOLUTION; ARTICLE; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; FILM; FREEZE DRYING; LYOPHILISATE; MICROSCOPE; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL; CHEMISTRY; DRUG DELIVERY SYSTEM; PHYSICAL CHEMISTRY; SYNTHESIS;

DRUG DELIVERY SYSTEMS; DRUG LIBERATION; DRUG STABILITY; LIPOSOMES; PHYSICOCHEMICAL PHENOMENA; PIROXICAM;

EID: 84930920676     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811666140723115852     Document Type: Article

References (36)

1. Kazi, K. M.; Mandal, A. S.; Biswas, N.; Guha, A.; Chatterjee, S.; Behera, M.; Kuotsu, K. Niosome: A future of targeted drug delivery systems. J. Adv. Pharm. Technol. Res., 2010, 1(4), 374-80.
2. Manosroi, A.; Wongtrakul, P.; Manosroi, J.; Sakai, H.; Sugawara, F.; Yuasa, M.; Abe, M. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf. B. Biointerfaces, 2003, 30(1-2), 129-138.
3. Mukherjee, B.; Patra, B.; Layek, B.; Mukherjee, A. Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study. Int. J. Nanomed., 2007, 2(2), 213-25.
4. Cortesi, R.; Esposito, E.; Corradini, F.; Sivieri, E.; Drechsler, M.; Rossi, A.; Scatturin, A.; Menegatti, E. Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies. Int. J. Pharm., 2007, 339(1-2), 52-60.
5. Uchegbu, I. F.; Vyas, S. P. Non-ionic surfactant based vesicles(niosomes) in drug delivery. Int. J. Pharm., 1998, 172(1-2), 33-70.
6. Uchegbu, I. F.; Florence, A. T. Nonionic Surfactant Vesicles (Niosomes)-Physical and Pharmaceutical Chemistry. Adv. Colloid Interface Sci., 1995, 58(1), 1-55.
7. van Winden, E. C. A.; Talsma, H.; Crommelin, D. J. A. Thermal analysis of freeze-dried liposome-carbohydrate mixtures with modulated temperature differential scanning calorimetry. J. Pharm. Sci., 1998, 87(2), 231-237.
8. Ingvarsson, P. T.; Yang, M. S.; Nielsen, H. M.; Rantanen, J.; Foged, C. Stabilization of liposomes during drying. Expert Opin. Drug Deliv., 2011, 8(3), 375-388.
9. Wathoni, N.; Uray, U.; Insani, C. Characterization and Optimization of Natural Maltodextrin-based Niosome. J. Applied Pharm. Sci., 2013, 3(07), 068-071.
10. Ahmed, A. M. S.; Ghourab, M. M.; Gad, S.; Qushawy, M. K. E. Design, Formulation, and Evaluation of Piroxicam Niosomal Gel. Int. J. Pharm. Tech. Res., 2014, 6(1), 185-195.
11. Yuksel, N.; Karatas, A.; Ozkan, Y.; Savaser, A.; Ozkan, S. A.; Baykara, T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm., 2003, 56(3), 453-459.
12. Nnamani, P. O.; Attama, A. A.; Kenechukwu, F. C.; Ibezim, E. C.; Adikwu, M. U. Pharmacodynamics of piroxicam from novel solid lipid microparticles formulated with homolipids from Bos indicus. Curr. Drug Deliv., 2013, 10(6), 645-55.
13. Ciobanu, M.; Heurtault, B.; Schultz, P.; Ruhlmann, C.; Muller, C. D.; Frisch, B. Layersome: Development and optimization of stable liposomes as drug delivery system. Int. J. Pharm., 2007, 344(1-2), 154-157.
14. Darwish, I. A.; Uchegbu, I. F. The evaluation of crown ether based niosomes as cation containing and cation sensitive drug delivery systems. Int. J. Pharm., 1997, 159(2), 207-213.
15. Arunothayanun, P.; Bernard, M. S.; Craig, D. Q. M.; Uchegbu, I. F.; Florence, A. T. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles(niosomes) formed from a hexadecyl diglycerol ether. Int. J. Pharm., 2000, 201(1), 7-14.
16. Sezgin-Bayindir, Z.; Yuksel, N. Investigation of formulation variables and excipient interaction on the production of niosomes. AAPS Pharm. Sci. Tech., 2012, 13(3), 826-35.
17. Bayindir, Z. S.; Yuksel, N. Characterization of Niosomes Prepared With Various Nonionic Surfactants for Paclitaxel Oral Delivery. J. Pharm. Sci., 2010, 99(4), 2049-2060.
18. Hu, F. Q.; Ren, G. F.; Yuan, H.; Du, Y. Z.; Zeng, S. Shell crosslinked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf. B Biointerfaces, 2006, 50(2), 97-103.
19. Yang, T.; Cui, F. D.; Choi, M. K.; Cho, J. W.; Chung, S. J.; Shim, C. K.; Kim, D. D. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int. J. Pharm., 2007, 338(1-2), 317-26.
20. USP30 (NF25), U. S. P. Piroxicam. In Piroxicam capsules, The United States Pharmacopeial Convention: 2007.
21. ICH Harmonised Tripartite Guideline Stability Testing of New Drug Substances and Products Q1a(R2). 2003.
22. Ferreira, H.; Matama, T.; Silva, R.; Silva, C.; Gomes, A. C.; Cavaco-Paulo, A. Functionalization of gauzes with liposomes entrapping an anti-inflammatory drug: A strategy to improve wound healing. React. Funct. Polym., 2013, 73(10), 1328-1334.
23. Chaw, C. S.; Kim, K. Y. A. Effect of formulation compositions on niosomal preparations. Pharm. Dev. Technol., 2013, 18(3), 667-672.
24. Muller, R. H.; Jacobs, C.; Kayser, O. Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev., 2001, 47(1), 3-19.
25. Akhter, S.; Kushwaha, S.; Warsi, M. H.; Anwar, M.; Ahmad, M. Z.; Ahmad, I.; Talegaonkar, S.; Khan, Z. I.; Khar, R. K.; Ahmad, F. J. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir. Drug Dev. Ind. Pharm., 2012, 38(1), 84-92.
26. Glavas-Dodov, M.; Fredro-Kumbaradzi, E.; Goracinova, K.; Simonoska, M.; Calis, S.; Trajkovic-Jolevskaa, S.; Hincal, A. A. The effects of lyophilization on the stability of liposomes containing 5-FU. Int. J. Pharm., 2005, 291(1-2), 79-86.
27. Lai, F.; Valenti, D.; Sinico, C.; Manconi, M.; Mendez, J. B.; Fadda, A. M. Phospholipid vesicles as carriers in aquaculture: preparation and stability study of thiamine hydrochloride-loaded liposomes. Curr. Drug Deliv., 2004, 1(2), 145-52.
28. Singh, G.; Dwivedi, H.; Saraf, S. K.; Saraf, S. A. Niosomal Delivery of Isoniazid-Development and Characterization. Trop. J. Pharm. Res., 2011, 10(2), 203-210.
29. Wu, L.; Zhang, J.; Watanabe, W. Physical and chemical stability of drug nanoparticles. Adv. Drug Deliv. Rev., 2011, 63(6), 456-69.
30. Guo, J.; Ping, Q.; Jiang, G.; Huang, L.; Tong, Y. Chitosan-coated liposomes: characterization and interaction with leuprolide. Int. J. Pharm., 2003, 260(2), 167-73.
31. Larsson, M.; Hill, A.; Duffy, J. Suspension Stability; Why Particle Size, Zeta Potential and Rheology are Important. Ann. Transactions-Nordic Rheology Soc., 2012, 20, 209-216.
32. Maitani, Y.; Aso, Y.; Yamada, A.; Yoshioka, S. Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency. Int. J. Pharm., 2008, 356(1-2), 69-75.
33. Martin, A. Physical pharmacy. 4th ed.; Lippincolt Williams & Wilkins: MD, USA, 1993.
34. Moritani, Y.; Nomura, S. M.; Morita, I.; Akiyoshi, K. Direct integration of cell-free-synthesized connexin-43 into liposomes and hemichannel formation. FEBS J., 2010, 277(16), 3343-3352.
35. Chattopadhyay, S.; Ehrman, S. H.; Venkataraman, C. Size distribution and dye release properties of submicron liposome aerosols. Powder Technol., 2013, 246, 530-538.
36. Paolino, D.; Cosco, D.; Muzzalupo, R.; Trapasso, E.; Picci, N.; Fresta, M. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int. J. Pharm., 2008, 353(1-2), 233-242.